Benjamin T. Marchello

Author

Mayo Clinic

Also Known As

Andrew D. Leavitt, B. T. Marchello, B.T. Marchello, Benjamin Marchello, Benjamin T. Marchello

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Montana Cancer Consortium Wayne State University Emory University

About

Benjamin T. Marchello is an author at Mayo Clinic specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	169
2	Pathology	3	3	106
3	Health Sciences	1	1	63
4	Anesthesia	1	1	63
5	Pharmacology	1	1	10

Benjamin T. Marchello

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Capecitabine and Oxaliplatin in the Preoperative Multimodality Treatment of Rectal Cancer: Surgical End Points From National Surgical Adjuvant Breast and Bowel Project Trial R-04 Michael J. O’Connell, Linda H. Colangelo, Robert W. Beart, Journal of Clinical Oncology	2014	438
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial Carmen J. Allegra, Greg Yothers, Michael J. O’Connell, JNCI Journal of the National Cancer Institute	2015	326
Comparative Effectiveness of Sphincter-Sparing Surgery Versus Abdominoperineal Resection in Rectal Cancer Marcia M. Russell, Patricia A. Ganz, Samia Lopa, Annals of Surgery	2014	84
Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB) Andrea Cheville, Jeff A. Sloan, Donald W. Northfelt, Supportive Care in Cancer Pain TherapySurgical OncologyPain MedicineNeuropathic PainSurgery	2009	63
Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance) Han‐Seung Yoon, Nathan R. Foster, J. Meyers, Annals of Oncology Ncctg N0871OncologyMedicinePathologyCancer Genomics	2015	57
Phase II Study of Temozolomide (TMZ) and Everolimus (RAD001) Therapy for Metastatic Melanoma Roxana Dronca, Jacob B. Allred, Domingo G. Pérez, American Journal of Clinical Oncology	2013	42
Southwest Oncology Group Phase II Trial (S0341) of Erlotinib (OSI-774) in Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2 Paul J. Hesketh, Kari Chansky, Antoinette J. Wozniak, Journal of Thoracic Oncology MedicineMetronomic TherapyPathologyBronchial NeoplasmPerformance Status	2008	39
Pharmacogenetic dosing by UGT1A1 genotype as first-line therapy for advanced small-bowel adenocarcinoma: A North Central Cancer Treatment Group (NCCTG) trial. Robert R. McWilliams, Michelle R. Mahoney, Benjamin T. Marchello, Journal of Clinical Oncology First-line TherapyGastrointestinal OncologyMedicinePharmacologyAdvanced Small-bowel Adenocarcinoma	2012	10

Page 1